X-group (possible homology)

838 Ribosomal protein S19

Ligands and drugs

3,318
Member domains
304
with ligand contacts (≤ 4 Å)
9.2% of members
202
with DrugDomain annotations
6.1% of members
6
with a DrugBank compound
0.2% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.

9
Proteins with classified ligands
3
Superclasses bound (of 23)
—
Superclasses per 20 proteins
fewer than 20 proteins: too few to compare at equal depth

The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.

SuperclassProteinsExpected
0.25×observed / expected4×
RatioSignificance
Mixed metal/non-metal compounds20.211×not tested
Organic acids and derivatives41.42.91×not tested
Homogeneous metal compounds74.41.61×not tested
enriched (q < 0.05)depleted (q < 0.05)not significantnot tested (expected < 5)

Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.

DrugBank compounds

DrugBankPDB ligandNameDomains
DB00120PHEPhenylalanine3
DB00128ASPAspartic acid2
DB00134METMethionine1

Most frequently bound compounds

PDB ligandNameDomains in contact
MGmetalMAGNESIUM ION222
OHXosmium (III) hexammine80
KmetalPOTASSIUM ION2
UNXUNKNOWN ATOM OR ION2